| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO | Interim CEO | Interim President And CEO +3 more
2 companies
Walker Neal serves as a CEO at ACRS and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 18 sells. Those positions are worth an estimated $9K at current prices.
Historically, Walker Neal's trades have earned a strong insider score of 85/100 across 13 rated trades. Over a 12-month horizon, 92.3% of those trades were profitable, with an average 12-month return of +60.7%.
The biggest single holding is ALDX (~$9K) as Director.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2023 | ACRS Aclaris Therapeutics, Inc. | Director | Sale+OE | 59,240 | $12.50 | $740,658.20 | -4.4% | -31.9% | -90.3% | |
| Feb 2, 2023 | ACRS Aclaris Therapeutics, Inc. | Director | Sell | 30,000 | $16.66 | $499,922.79 | -2.5% | -37.2% | -91.6% | |
| Jan 4, 2023 | ACRS Aclaris Therapeutics, Inc. | Director | Sell | 40,000 | $15.11 | $604,555.77 | -3.2% | -42.1% | -92.7% | |
| Apr 25, 2022 | ACRS Aclaris Therapeutics, Inc. | President And CEO | Sell | 70,000 | $15.15 | $1,060,701.00 | -5.3% | +0.5% | -41.4% | |
| Mar 11, 2022 | ACRS Aclaris Therapeutics, Inc. | President And CEO | Sell | 56,303 | $15.91 | $896,045.35 | -4.1% | -4.6% | -50.1% | |
| Feb 9, 2022 | ACRS Aclaris Therapeutics, Inc. | President And CEO | Sell | 3,595 | $12.66 | $45,513.42 | -0.3% | -12.7% | +8.8% | |
| Jun 2, 2021 | ACRS Aclaris Therapeutics, Inc. | President And CEO | Sale+OE | 33,260 | $21.64 | $719,734.92 | -2.6% | -25.4% | -33.4% | |
| Apr 22, 2021 | ACRS Aclaris Therapeutics, Inc. | President And CEO | Sell | 30,000 | $26.84 | $805,239.00 | -2.5% | -41.1% | -43.6% | |
| Apr 5, 2018 | ACRS Aclaris Therapeutics, Inc. | President And CEO | Buy | 10,000 | $16.75 | $167,500.00 | +1.1% | - | - |